BPO 0.00% 0.3¢ bioprospect limited

further positive results from ap778 field trials, page-3

  1. 2,036 Posts.
    Trials doing well, can't wait for the product to hit the 3 billion $$$ market, BPO will be workth $$$$$

    · Market size for termite management products is estimated at US$ 3 billion globally.

    BioProspect Limited (ASX:BPO) today advise that field trials for its natural termite product AP778 continue to show positive results for the protection of timber from
    termites after an interim assessment at the 18 month period.

    · Potential for improved performance following formulation work.

    · Trial results will form part of the registration package in Australia upon completion.

    · Low levels of toxicity are a key advantage over existing commercial products.

 
watchlist Created with Sketch. Add BPO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.